![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/22 | (2006.01) |
(11) | Number of the document | 2187964 |
(13) | Kind of document | T |
(96) | European patent application number | 08782673.1 |
Date of filing the European patent application | 2008-08-08 | |
(97) | Date of publication of the European application | 2010-05-26 |
(45) | Date of publication and mention of the grant of the patent | 2014-10-08 |
(46) | Date of publication of the claims translation | 2015-01-26 |
(86) | Number | PCT/US2008/072561 |
Date | 2008-08-08 |
(87) | Number | WO 2009/023540 |
Date | 2009-02-19 |
(30) | Number | Date | Country code |
964224 P | 2007-08-10 | US | |
994526 P | 2007-09-20 | US | |
62860 P | 2008-01-28 | US | |
79259 P | 2008-07-09 | US |
(72) |
REINHARDT, Joel, C., US
MACDONALD, Lynn, US
TORRES, Richard, US
MORRA, Marc, R., US
MARTIN, Joel, H., US
|
(73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Didelio giminingumo žmogaus antikūnai prieš žmogaus nervų augimo faktorių |
HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN NERVE GROWTH FACTOR |
Payment date | Validity (years) | Amount | |
2025-07-23 | 18 | 347.00 EUR |
2026-08-08 |